Sign up
Log in
Seer to present AI-driven multi-cancer screening proteomics at ASMS conference
Share
Listen to the news
Seer to present AI-driven multi-cancer screening proteomics at ASMS conference
  • Seer will participate in the ASMS Annual Conference May 31–June 4, 2026, in San Diego.
  • A breakfast symposium on AI-driven multi-cancer screening is scheduled for June 1, 2026.
  • An oral presentation on Radiant DIA and the Fulcrum Pipeline is scheduled for June 2, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seer Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605261605PRIMZONEFULLFEED9725670) on May 26, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.